Axogen Inc Stock Performance
| AXGN Stock | USD 34.85 0.85 2.50% |
On a scale of 0 to 100, Axogen holds a performance score of 16. The firm shows a Beta (market volatility) of -0.38, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Axogen are expected to decrease at a much lower rate. During the bear market, Axogen is likely to outperform the market. Please check Axogen's semi variance, and the relationship between the treynor ratio and daily balance of power , to make a quick decision on whether Axogen's price patterns will revert.
Risk-Adjusted Performance
Solid
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Axogen Inc are ranked lower than 16 (%) of all global equities and portfolios over the last 90 days. In spite of very weak technical and fundamental indicators, Axogen displayed solid returns over the last few months and may actually be approaching a breakup point. ...more
Actual Historical Performance (%)
One Day Return 2.5 | Five Day Return 9.28 | Year To Date Return 12.42 | Ten Year Return 587.38 | All Time Return 771.25 |
Last Split Factor 105:100 | Dividend Date 2010-02-12 | Ex Dividend Date 2010-01-27 | Last Split Date 1994-07-11 |
1 | Disposition of 4073 shares by Weiler Kathy Johnson of Axogen at 10.61 subject to Rule 16b-3 | 11/12/2025 |
2 | What analyst consensus says on Axogen Inc. stock - July 2025 Selloffs Weekly High Return Stock Forecasts - newser.com | 11/18/2025 |
3 | Disposition of 20000 shares by Hartley Lindsey Marie of Axogen at 15.22 subject to Rule 16b-3 | 12/08/2025 |
4 | Disposition of 8545 shares by Johnson John of Axogen at 6.3 subject to Rule 16b-3 | 12/09/2025 |
5 | Disposition of 25000 shares by Michael Dale of Axogen at 30.0 subject to Rule 16b-3 | 12/10/2025 |
6 | Trade Alert President Of Axogen Michael Dale Has Sold Stock | 12/12/2025 |
7 | AxoGen, Inc. Short Interest Down 17.8 percent in December | 12/31/2025 |
8 | AxoGen Trading 8 percent Higher Time to Buy | 01/09/2026 |
9 | Axogen CEO Axed 25,000 Shares From His Direct Holdings | 01/14/2026 |
10 | Axogen Announces Proposed Public Offering of Common Stock | 01/21/2026 |
11 | Axogen Upsized Equity Raise Shifts Debt Profile And Valuation Focus | 01/23/2026 |
12 | Axogen Inc Trading Down 2.86 percent on Jan 28 - GuruFocus | 01/28/2026 |
| Begin Period Cash Flow | 37 M | |
| Total Cashflows From Investing Activities | -10.3 M |
Axogen Relative Risk vs. Return Landscape
If you would invest 2,325 in Axogen Inc on November 2, 2025 and sell it today you would earn a total of 1,160 from holding Axogen Inc or generate 49.89% return on investment over 90 days. Axogen Inc is currently generating 0.7205% in daily expected returns and assumes 3.3927% risk (volatility on return distribution) over the 90 days horizon. In different words, 30% of stocks are less volatile than Axogen, and 86% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Axogen Target Price Odds to finish over Current Price
The tendency of Axogen Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 34.85 | 90 days | 34.85 | about 8.64 |
Based on a normal probability distribution, the odds of Axogen to move above the current price in 90 days from now is about 8.64 (This Axogen Inc probability density function shows the probability of Axogen Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days Axogen Inc has a beta of -0.38. This suggests as returns on the benchmark increase, returns on holding Axogen are expected to decrease at a much lower rate. During a bear market, however, Axogen Inc is likely to outperform the market. Moreover Axogen Inc has an alpha of 1.0489, implying that it can generate a 1.05 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Axogen Price Density |
| Price |
Predictive Modules for Axogen
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Axogen Inc. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Axogen Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Axogen is not an exception. The market had few large corrections towards the Axogen's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Axogen Inc, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Axogen within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 1.05 | |
β | Beta against Dow Jones | -0.38 | |
σ | Overall volatility | 4.43 | |
Ir | Information ratio | 0.23 |
Axogen Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Axogen for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Axogen Inc can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Axogen Inc appears to be risky and price may revert if volatility continues | |
| The company reported the previous year's revenue of 187.34 M. Net Loss for the year was (9.96 M) with profit before overhead, payroll, taxes, and interest of 160.52 M. | |
| Axogen Inc has a frail financial position based on the latest SEC disclosures | |
| Over 87.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from kalkinemedia.com: Sana Biotechnology shaping Nasdaq 100 composition |
Axogen Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Axogen Stock often depends not only on the future outlook of the current and potential Axogen's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Axogen's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 44.3 M | |
| Cash And Short Term Investments | 33.5 M |
Axogen Fundamentals Growth
Axogen Stock prices reflect investors' perceptions of the future prospects and financial health of Axogen, and Axogen fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Axogen Stock performance.
| Return On Equity | -0.0191 | ||||
| Return On Asset | 0.0121 | ||||
| Profit Margin | (0.01) % | ||||
| Operating Margin | 0.03 % | ||||
| Current Valuation | 1.74 B | ||||
| Shares Outstanding | 50.17 M | ||||
| Price To Earning | (47.07) X | ||||
| Price To Book | 14.12 X | ||||
| Price To Sales | 7.99 X | ||||
| Revenue | 187.34 M | ||||
| Gross Profit | 160.52 M | ||||
| EBITDA | 6.08 M | ||||
| Net Income | (9.96 M) | ||||
| Cash And Equivalents | 58.03 M | ||||
| Cash Per Share | 1.37 X | ||||
| Total Debt | 68.69 M | ||||
| Debt To Equity | 0.71 % | ||||
| Current Ratio | 4.52 X | ||||
| Book Value Per Share | 2.62 X | ||||
| Cash Flow From Operations | 4.54 M | ||||
| Earnings Per Share | (0.05) X | ||||
| Market Capitalization | 1.71 B | ||||
| Total Asset | 203.73 M | ||||
| Retained Earnings | (291.26 M) | ||||
| Working Capital | 68.61 M | ||||
| Current Asset | 35.05 M | ||||
| Current Liabilities | 3.71 M | ||||
About Axogen Performance
By examining Axogen's fundamental ratios, stakeholders can obtain critical insights into Axogen's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Axogen is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 240.31 | 172.82 | |
| Return On Tangible Assets | (0.06) | (0.06) | |
| Return On Capital Employed | (0.02) | (0.02) | |
| Return On Assets | (0.06) | (0.06) | |
| Return On Equity | (0.11) | (0.12) |
Things to note about Axogen Inc performance evaluation
Checking the ongoing alerts about Axogen for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Axogen Inc help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Axogen Inc appears to be risky and price may revert if volatility continues | |
| The company reported the previous year's revenue of 187.34 M. Net Loss for the year was (9.96 M) with profit before overhead, payroll, taxes, and interest of 160.52 M. | |
| Axogen Inc has a frail financial position based on the latest SEC disclosures | |
| Over 87.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from kalkinemedia.com: Sana Biotechnology shaping Nasdaq 100 composition |
- Analyzing Axogen's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Axogen's stock is overvalued or undervalued compared to its peers.
- Examining Axogen's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Axogen's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Axogen's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Axogen's stock. These opinions can provide insight into Axogen's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Axogen Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in census. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Will Health Care Equipment & Supplies sector continue expanding? Could Axogen diversify its offerings? Factors like these will boost the valuation of Axogen. If investors know Axogen will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Axogen data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (0.05) | Revenue Per Share | Quarterly Revenue Growth 0.235 | Return On Assets | Return On Equity |
Investors evaluate Axogen Inc using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Axogen's intrinsic value—the estimated true worth—helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Axogen's market price to deviate significantly from intrinsic value.
Understanding that Axogen's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Axogen represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Conversely, Axogen's market price signifies the transaction level at which participants voluntarily complete trades.